Pando

Curated by Signal

Developer of AI-based synthetic biology platform for drug discovery

Overview

Developer of AI-based synthetic biology platform for drug discovery. It uses generative AI and high-throughput experiments to discover, and design biological molecules and systems. It provides treatments by understanding human diseases from genomes to interactomes, from individual proteins to protein-protein interaction networks.

Key facts

Founded: 2023
Headquarters: Watertown, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Design Clinicals
Medication reconciliation platform for care coordination
Health TechnologySan Francisco, United States
InfraSonic Monitoring
Developer of cardiac output monitoring platform
Health TechnologyNew York City, United States
Bellacurve
Platform offering organic dietary supplements
Health TechnologyChicago, United States

About Pando

What does Pando do?

Developer of AI-based synthetic biology platform for drug discovery.

Where is Pando headquartered?

Pando is headquartered in Watertown, United States.

When was Pando founded?

Pando was founded in 2023.

Which sector is Pando in?

Pando operates in Health Technology.

Who are Pando's competitors?

Companies similar to Pando include Design Clinicals, InfraSonic Monitoring, and Bellacurve.